Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
President Trump is likely to embrace the Medicare drug price negotiations that was initiated under the Biden administration, though the president could make some tweaks to put his own spin on it. The ...
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...
President Trump will continue to pursue the policy of Medicare pricing negotiation introduced by former President Biden's ...
Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results